• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: Gammalinolenic acid
Date Designated: 07/27/1994
Orphan Designation: Treatment of juvenile rheumatoid arthritis.
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Zurier, Robert B. M.D.
University of Massachusetts Medical Center
55 Lake Avenue
Worcester, Massachusetts 01655
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-